AMY1A
MOLECULAR TARGETamylase alpha 1A
AMY1A (amylase alpha 1A) is targeted by 3 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting AMY1A
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | pentagalloyl glucose | 3.26 | 25 |
| 2 | quercetagetin | 3.26 | 25 |
| 3 | scutellarein | 1.10 | 2 |
About AMY1A as a Drug Target
AMY1A (amylase alpha 1A) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 3 compounds with documented AMY1A interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
AMY1A inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.